Neogen Chemicals to acquire N Butyl Lithium manufacturer BuLi Chem


Neogen Chemicals, an Indian bromine, lithium-based specialty chemicals and advanced intermediates manufacturer, has agreed to acquire BuLi Chemicals India (BuLi Chem) from Livent, a US-based chemical manufacturer.

The financial terms of the deal were not disclosed.

BuLi Chem has a proprietary technology for manufacturing N Butyl Lithium and other organolithium products using lithium metal, which are main reagents for lithiation reaction that is employed in manufacturing various complex pharmaceutical and agrochemical intermediates.

See also  Tata Power to sell Singapore-based Trust Energy Resources for $285m

Walter Czarnecki — Livent Chief Commercial Officer said: “We believe this will be a great outcome for all parties. Neogen is focused on the pharmaceuticals and chemicals market in India and shares Livent’s commitment to employees and local communities.

“We look forward to seeing this facility and our former colleagues thrive under the new ownership and will do everything we can to support a smooth transition.”

See also  Gogoro, Belrise to set up battery swapping infrastructure in Maharashtra

The N Butyl Lithium manufactured by BuLi Chem is supplied to various pharma and agrochemical companies in India and around the world.

Dr. Harin Kanani — Neogen Chemicals Managing Director said: “We are glad to be acquiring BuLi Chem, which houses the Indian operations of Livent USA Corp – one of the global leaders in speciality lithium technology.

See also  Dr. Reddy’s Laboratories Q1 FY22 profit down by 1% to Rs 571cr

“We are happy to welcome the employees of BuLi Chem who have deep experience of more than a decade in handling Organo Lithium Chemistry to the Neogen family. They have managed to develop one of the few facilities outside of China for this chemistry with strong track record in safety and sustainability.”

Share This